Brichem Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.35 M
as on 16-11-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.11 Cr
as on 16-11-2024
- Satisfied Charges ₹ 19.20 Cr
as on 16-11-2024
- Revenue 166.21%
(FY 2023)
- Profit -2392.44%
(FY 2023)
- Ebitda -208.27%
(FY 2023)
- Net Worth -226.55%
(FY 2023)
- Total Assets 29.58%
(FY 2023)
About Brichem Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.35 M.
The company currently has active open charges totaling ₹13.11 Cr. The company has closed loans amounting to ₹19.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Paragkumar Bhavsar, Rajeshkumar Gami, Mittalkumar Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304GJ2016PTC094569
- Company No.
094569
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Brichem Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paragkumar Bhavsar  | Director | 05-Dec-2016 | Current |
| Rajeshkumar Gami | Director | 05-Dec-2016 | Current |
| Mittalkumar Patel | Director | 31-Jul-2019 | Current |
| Aashay Patel | Director | 31-Jul-2019 | Current |
Financial Performance of Brichem Sciences.
Brichem Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 166.21% increase. The company also saw a substantial fall in profitability, with a 2392.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 226.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brichem Sciences?
In 2023, Brichem Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vidman Pharmaceuticals Private LimitedActive 7 years 5 monthsRajeshkumar Gami, Mittalkumar Patel and 1 more are mutual person
Maharshi Pharma Chem Private LimitedActive 26 years 3 monthsParagkumar Bhavsar, Mittalkumar Patel and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Feb 2024 | ₹13.11 Cr | Open |
Others Creation Date: 10 Sep 2019 | ₹18.40 Cr | Satisfied |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 09 Feb 2018 | ₹8.00 M | Satisfied |
How Many Employees Work at Brichem Sciences?
Brichem Sciences has a workforce of 80 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brichem Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brichem Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
